-+ 0.00%
-+ 0.00%
-+ 0.00%

Fulcrum Therapeutics initial beneficial ownership filing shows Kevin Tang as 10% owner

PUBT·07/15/2026 23:50:04
Listen to the news
Fulcrum Therapeutics initial beneficial ownership filing shows Kevin Tang as 10% owner
  • Fulcrum Therapeutics Form 3 filed for Kevin Tang and Tang Capital Management, listed as 10% owners.
  • Disclosure shows indirect beneficial ownership of 6,663,383 shares of common stock.
  • Event date July 13, 2026; filing signed July 15, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulcrum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178579-26-000013), on July 15, 2026, and is solely responsible for the information contained therein.